Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial.

Autor: Squire, Iain B.1,2 (AUTHOR), Gabrielsen, Anders3 (AUTHOR), Greasley, Peter J.3 (AUTHOR), Wernevik, Linda3 (AUTHOR), Hartleib‐Geschwindner, Judith4 (AUTHOR), Holden, Julie5 (AUTHOR), Johansson, Susanne3 (AUTHOR), Rudvik, Anna6 (AUTHOR), Sánchez, José6 (AUTHOR), Bamberg, Krister7 (AUTHOR), Melin, Johanna8 (AUTHOR), Whittaker, Andrew9 (AUTHOR) andrew.whittaker1@astrazeneca.com
Zdroj: CTS: Clinical & Translational Science. Oct2022, Vol. 15 Issue 10, p2493-2504. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje